Prostate cancer: Where are we and where are we going?

被引：21

作者：

Denmeade, SR

Isaacs, JT

机构：

[1] JOHNS HOPKINS ONCOL CTR, BALTIMORE, MD 21231 USA

[2] JOHNS HOPKINS UNIV, SCH MED, JAMES BUCHANAN BRADY UROL INST, BALTIMORE, MD USA

[3] JOHNS HOPKINS UNIV, SCH MED, DEPT UROL, BALTIMORE, MD 21205 USA

来源：

BRITISH JOURNAL OF UROLOGY | 1997年 / 79卷

关键词：

D O I：

10.1111/j.1464-410X.1997.tb00794.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 7

页数：6

共 43 条

[11] ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].

FOLKMAN, J .

NATURE MEDICINE, 1995, 1 (01) :27-31

[12]

Furuya Y, 1996, CLIN CANCER RES, V2, P389

[13] ANDROGEN ABLATION-INDUCED PROGRAMMED DEATH OF PROSTATIC GLANDULAR CELLS DOES NOT INVOLVE RECRUITMENT INTO A DEFECTIVE CELL-CYCLE OR P53 INDUCTION [J].

FURUYA, Y ;

LIN, XHS ;

WALSH, JC ;

NELSON, WG ;

ISAACS, JT .

ENDOCRINOLOGY, 1995, 136 (05) :1898-1906

[14]

FURUYA Y, 1994, CANCER RES, V54, P6167

[15] PROLIFERATION-DEPENDENT VS INDEPENDENT PROGRAMMED CELL-DEATH OF PROSTATIC-CANCER CELLS INVOLVES DISTINCT GENE-REGULATION [J].

FURUYA, Y ;

ISAACS, JT .

PROSTATE, 1994, 25 (06) :301-309

[16] PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING [J].

GLEASON, DF ;

MELLINGE.GT .

JOURNAL OF UROLOGY, 1974, 111 (01) :58-64

[17]

GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125

[18] PERSON-YEARS OF LIFE LOST DUE TO CANCER IN THE UNITED-STATES, 1970 AND 1984 [J].

HORM, JW ;

SONDIK, EJ .

AMERICAN JOURNAL OF PUBLIC HEALTH, 1989, 79 (11) :1490-1493

[19]

ICHIKAWA T, 1992, CANCER RES, V52, P2916

[20]

ISAACS JT, 1989, CANCER RES, V49, P6290

← 1 2 3 4 5 →